Will ChatGPT or Gemini tell me what my high glucose means?

ChatGPT and Gemini can provide general information about high glucose levels but lack the medical context and personalized analysis needed for proper health interpretation. For comprehensive blood test analysis with actionable insights, specialized AI tools designed for health optimization offer superior results.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

The short answer: Yes, but with significant limitations

Both ChatGPT and Google's Gemini can provide basic information about high glucose levels when you share your blood test results. They can explain what glucose is, why it's important, and what elevated levels might indicate. However, these general-purpose AI chatbots weren't designed for medical interpretation and lack several crucial capabilities that make them less than ideal for understanding your personal health data.

While these AI assistants can be helpful starting points for understanding glucose basics, they cannot replace professional medical advice or provide the personalized, contextual analysis that specialized health AI tools can offer. Understanding these limitations is essential before relying on ChatGPT or Gemini for health insights.

What ChatGPT and Gemini can tell you about high glucose

Basic glucose education

Both AI chatbots excel at explaining fundamental concepts about blood glucose. They can tell you that glucose is your body's primary energy source, derived from the foods you eat, particularly carbohydrates. They'll explain how insulin helps cells absorb glucose and why maintaining proper glucose levels is crucial for overall health.

Glucose Level Categories and Health Implications

Test TypeNormalPrediabetesDiabetes
Fasting GlucoseFasting Glucose< 100 mg/dL100-125 mg/dL≥ 126 mg/dL
HbA1cHbA1c< 5.7%5.7-6.4%≥ 6.5%
Random GlucoseRandom Glucose< 140 mg/dL140-199 mg/dL≥ 200 mg/dL

Diagnosis requires confirmation with repeat testing. Optimal levels for longevity may be lower than 'normal' ranges.

These AI tools can also describe the difference between fasting glucose, random glucose, and HbA1c tests, helping you understand which test you've taken and what each measures. They can explain that fasting glucose shows your blood sugar after not eating for 8-12 hours, while HbA1c reflects your average glucose over the past 2-3 months.

Reference range interpretation

ChatGPT and Gemini can compare your glucose results to standard reference ranges. They'll typically tell you that normal fasting glucose is below 100 mg/dL, prediabetes ranges from 100-125 mg/dL, and diabetes is diagnosed at 126 mg/dL or higher. For HbA1c, they'll explain that normal is below 5.7%, prediabetes is 5.7-6.4%, and diabetes is 6.5% or higher.

Understanding these reference ranges is important, but it's just the beginning. Your glucose levels need to be interpreted in context with your other health markers, medications, and personal health history.

General health implications

These AI assistants can outline potential health implications of high glucose, including increased risk of type 2 diabetes, cardiovascular disease, kidney problems, and nerve damage. They can explain how chronically elevated glucose can damage blood vessels and organs over time, leading to serious complications if left unmanaged.

They might also mention common symptoms of high blood sugar, such as increased thirst, frequent urination, fatigue, blurred vision, and slow wound healing. However, they cannot assess whether your specific symptoms are related to your glucose levels or other factors.

Critical limitations of general AI chatbots for glucose interpretation

Lack of personalized context

Neither ChatGPT nor Gemini can access your complete health profile unless you manually provide every detail. They don't know your age, weight, activity level, family history, current medications, or other health conditions. A glucose level of 110 mg/dL might be concerning for a young, healthy individual but less worrying for someone older or with other risk factors.

These chatbots also can't consider important factors like recent illness, stress, medications (such as steroids), or even the timing of your last meal, all of which can significantly affect glucose readings. Without this context, their interpretations remain generic and potentially misleading.

No trend analysis or historical data

One of the most valuable aspects of glucose monitoring is tracking changes over time. A single elevated reading might be less concerning than a steady upward trend over months. ChatGPT and Gemini can't store or remember your previous results, making it impossible for them to identify important patterns or improvements in your metabolic health.

They also can't correlate your glucose patterns with other biomarkers like insulin, C-peptide, or inflammatory markers that provide a more complete picture of your metabolic health. This limitation significantly reduces their ability to provide meaningful insights about your glucose management.

Generic recommendations only

While these AI tools can suggest general lifestyle modifications like reducing sugar intake, increasing exercise, and managing stress, they cannot provide personalized recommendations based on your specific situation. They don't know if you're already following a low-carb diet, have mobility limitations that affect exercise options, or take medications that interact with certain foods.

Why specialized health AI provides superior glucose insights

Unlike general-purpose chatbots, specialized health AI platforms are designed specifically for biomarker interpretation and health optimization. These tools offer several key advantages when analyzing glucose and other metabolic markers.

Comprehensive metabolic analysis

Specialized health AI doesn't just look at glucose in isolation. It analyzes your complete metabolic panel, including insulin levels, HbA1c, lipid profile, and inflammatory markers to provide a holistic view of your metabolic health. This comprehensive approach helps identify insulin resistance, metabolic syndrome, or other conditions that might not be apparent from glucose levels alone.

For those serious about understanding and optimizing their metabolic health, SiPhox Health's free upload service allows you to upload past blood test results and receive comprehensive AI-driven analysis that goes far beyond what general chatbots can provide.

Personalized recommendations and tracking

Purpose-built health AI platforms can track your glucose trends over time, correlate them with lifestyle factors, and provide personalized recommendations based on your unique profile. They can identify patterns like dawn phenomenon (early morning glucose spikes) or post-meal glucose responses that require different management strategies.

These platforms can also integrate data from continuous glucose monitors (CGMs), providing real-time insights into how specific foods, exercise, sleep, and stress affect your glucose levels. This level of personalization is impossible with general AI chatbots.

How to get meaningful insights about your glucose levels

Start with comprehensive testing

Understanding your glucose levels requires more than a single fasting glucose test. Comprehensive metabolic testing should include fasting glucose, HbA1c, insulin, and C-peptide to fully assess your metabolic health. Additional markers like lipid panels and inflammatory markers provide important context for understanding your cardiovascular risk associated with glucose abnormalities.

Regular testing every 3-6 months allows you to track trends and see how lifestyle changes affect your glucose control. This frequency is especially important if you have prediabetes or are actively working to improve your metabolic health.

Leverage specialized AI for interpretation

Once you have your test results, using specialized health AI provides far more value than general chatbots. Sai, SiPhox Health's AI health optimization expert, is specifically designed to analyze biomarker data and provide personalized insights based on your complete health profile.

Sai can help you understand not just what your glucose levels mean, but how they relate to your other biomarkers, lifestyle factors, and health goals. It provides actionable recommendations tailored to your specific situation, whether you're working to prevent diabetes, optimize athletic performance, or improve overall metabolic health.

When to seek professional medical advice

While AI tools can provide valuable insights, certain situations always require professional medical consultation:

  • Fasting glucose consistently above 126 mg/dL or HbA1c above 6.5%
  • Symptoms of diabetes such as excessive thirst, frequent urination, or unexplained weight loss
  • Glucose levels that don't improve despite lifestyle changes
  • Need for medication management or adjustment
  • Pregnancy or planning to become pregnant with elevated glucose
  • Other health conditions that complicate glucose management

Healthcare providers can perform additional testing, prescribe medications if needed, and create comprehensive treatment plans that address all aspects of your health.

The future of AI-powered glucose management

As AI technology advances, we're seeing increasingly sophisticated tools for glucose management and diabetes prevention. Future developments will likely include AI that can predict glucose trends hours in advance, provide real-time dietary recommendations based on continuous monitoring, and even adjust insulin dosing for those with diabetes.

However, the key to benefiting from these advances is choosing the right tools. While ChatGPT and Gemini represent impressive achievements in general AI, health optimization requires specialized platforms designed with medical expertise and your long-term wellness in mind.

Taking control of your metabolic health

Your glucose levels are a critical indicator of metabolic health, and understanding them properly can help prevent serious health conditions. While ChatGPT and Gemini can provide basic education about glucose, they lack the specialized capabilities needed for comprehensive health analysis.

For those serious about optimizing their metabolic health, combining regular comprehensive testing with specialized AI analysis provides the most effective approach. By choosing tools designed specifically for health data interpretation, you can transform confusing lab results into clear, actionable insights that help you achieve your wellness goals.

Whether you're working to prevent diabetes, improve energy levels, or optimize athletic performance, understanding your glucose patterns is just the beginning. With the right tools and support, you can take control of your metabolic health and build a foundation for long-term wellness.

References

  1. American Diabetes Association. (2024). Standards of Medical Care in Diabetes-2024. Diabetes Care, 47(Suppl 1), S1-S321.[Link][DOI]
  2. Echouffo-Tcheugui, J. B., & Selvin, E. (2021). Prediabetes and What It Means: The Epidemiological Evidence. Annual Review of Public Health, 42, 59-77.[PubMed][DOI]
  3. Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012). Prediabetes: a high-risk state for diabetes development. The Lancet, 379(9833), 2279-2290.[PubMed][DOI]
  4. Nathan, D. M., et al. (2022). Glycemic control and vascular complications in type 2 diabetes. New England Journal of Medicine, 387(23), 2113-2124.[PubMed][DOI]
  5. Bergenstal, R. M., et al. (2022). Continuous glucose monitoring versus self-monitoring of blood glucose in adults with type 2 diabetes. JAMA, 328(12), 1199-1208.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my glucose at home?

You can test your glucose at home with SiPhox Health's Heart & Metabolic Program, which includes HbA1c testing along with comprehensive metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What's the difference between ChatGPT and specialized health AI for glucose analysis?

ChatGPT provides general information about glucose but lacks personalization, trend tracking, and medical context. Specialized health AI like Sai offers personalized analysis based on your complete health profile, tracks changes over time, and provides actionable recommendations specific to your situation.

Can I upload my existing glucose test results for AI analysis?

Yes, you can upload your past blood test results to SiPhox Health's free upload service for comprehensive AI-driven analysis. This service extracts and interprets your results, providing personalized insights and recommendations beyond what general chatbots can offer.

What glucose levels should I be concerned about?

Fasting glucose above 100 mg/dL or HbA1c above 5.7% indicates prediabetes, while levels above 126 mg/dL (fasting) or 6.5% (HbA1c) suggest diabetes. However, optimal levels for health and longevity may be even lower. Consult with healthcare providers for personalized targets based on your health profile.

How often should I test my glucose levels?

For most people monitoring metabolic health, testing every 3-6 months is recommended. Those with prediabetes or actively working to improve glucose control may benefit from more frequent testing. Regular monitoring helps track trends and assess the effectiveness of lifestyle changes.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details